EU CLOs’ overall exposure to Pharmanovia Bidco TL is approximately EUR 787.9 million. As of 27 January 2026, 264 EU CLO deals, managed by 26 managers, reported an average deal-level exposure of around 79 bps.
For existing premium subscribers, please log in here.
If you'd like to find out more about premium subscription, please submit the form below: